Our Department Mission....Delivering Excellence and Trust in Pharmaceutical Care through a Culture of Precision.
Search results for:

INFLIXIMAB-DYYB

INFLIXIMAB-DYYB
Drug Name Form Strength Non-Formulary Notes
INFLECTRA  


Comments:

Biosimilar product for infliximab (Remicade.)  Infliximab-DYYB is GMC's preferred agent, however, medication selection will be driven by payer, patient, and prescriber choice.  This is NOT an approved automatic substitution.  Infusion guidelines are the same as those for Remicade.


Last updated: Jun. 18, 2024


This site is intended for the staff of Genesis Health System.
While others may view accessible pages, Genesis Health System makes no warranty, express or implied,
as to the use of this information outside of Genesis Health System.